-
The Wilmington-based biopharmaceutical company Incyte is set to begin clinical trials for a drug that may be able to treat patients with severe cases of…
-
A Delaware-based biopharmaceutical company has the go-ahead from the Food and Drug Administration (FDA) to test one of its drugs as a possible COVID-19…
-
A global biopharmaceutical company based in Delaware is working to get one of its drugs approved to treat the new coronavirus disease. Officials at Incyte…
-
A global biopharmaceutical company based in Delaware is working to get one of its drugs approved to treat the new coronavirus disease. Officials at Incyte…
-
Toward the end of 2017, Wilmington-based pharmaceutical company Incyte announced it was starting a clinical trial for a drug it hopes could be used to…
-
Incyte announced Wednesday it has started a clinical trial to treat people with a rare blood cancer, using a drug they bought the rights to develop in…
-
Former founders of Wilmington-based biotech company Incyte have filed with the United States Securities and Exchange Commission to start a new company in…
-
Listen to this week's edition of The Green:Or listen to individual stories below:As the Blue Rocks kick-off a new season at Frawley Stadium and the…
-
With some patients who receive a bone marrow transplant to treat leukemia or other types of blood cancers, a rare condition called graft-versus-host…
-
Pharmaceutical corporation Incyte will be expanding its base in Delaware. New Castle County Council approved Incyte’s plan to build office space that can…